ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Geriatric Medicine

Top Geriatric Medicine Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ROBERT PEARLSTEIN D.O.

Geriatric Medicine

103,576

$5.85M

2523
2127 are 65+

15%
patients receiving schedule two controlled substances

Avg: 14%

6%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $50

GAINNEOS GOLDIE MD

Geriatric Medicine

17,711

$803K

858
820 are 65+

1%
patients receiving schedule two controlled substances

Avg: 14%

24%
patients receiving schedule three controlled substances

Avg: 6%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $50

RICHARD GRANT MD

Geriatric Medicine

26,324

$1.31M

689
388 are 65+

9%
patients receiving schedule two controlled substances

Avg: 14%

7%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $50

BOHDAN MARTYNEC M.D.

Geriatric Medicine

13,836

$877K

672
627 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$63
Average prescription price

Avg: $50

MARIAN BRYCE D.O.

Geriatric Medicine

17,741

$937K

662
554 are 65+

18%
patients receiving schedule two controlled substances

Avg: 14%

6%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $50

JOEL POMERANTZ M.D.

Geriatric Medicine

22,445

$1.22M

651
548 are 65+

17%
patients receiving schedule two controlled substances

Avg: 14%

8%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $50

MELANIE JEWELL MD

Geriatric Medicine

12,055

$715K

637
545 are 65+

5%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $50

UMESH GOLANI MD

Geriatric Medicine

22,762

$1.13M

629
477 are 65+

17%
patients receiving schedule two controlled substances

Avg: 14%

17%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $50

PRIYA VASDEV M.D.

Geriatric Medicine

20,631

$1.59M

620
483 are 65+

26%
patients receiving schedule two controlled substances

Avg: 14%

6%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$77
Average prescription price

Avg: $50

SARAH SHINN MD

Geriatric Medicine

13,249

$841K

570
462 are 65+

6%
patients receiving schedule two controlled substances

Avg: 14%

10%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$63
Average prescription price

Avg: $50

GARY PASQUALICCHIO DO

Geriatric Medicine

18,288

$1.1M

546
447 are 65+

18%
patients receiving schedule two controlled substances

Avg: 14%

30%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $50

JAY ELDER M.D.

Geriatric Medicine

16,412

$902K

529
438 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $50

SUPRIYO GHOSH MD

Geriatric Medicine

8,955

$599K

526
471 are 65+

6%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $50

HARRY HUTCHINSON DO

Geriatric Medicine

14,326

$823K

519
471 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $50

EMMANUEL OKOLO MD

Geriatric Medicine

16,698

$884K

515
350 are 65+

13%
patients receiving schedule two controlled substances

Avg: 14%

4%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $50

SUSAN MOYER MD

Geriatric Medicine

6,899

$459K

513
510 are 65+

4%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $50

ZACHARY SIMPSON MD

Geriatric Medicine

25,361

$1.24M

498
489 are 65+

12%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $50

RACHEL SHIPLEY M.D.

Geriatric Medicine

8,070

$413K

490
421 are 65+

9%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $50

MATTHEW COPPOLA M.D.

Geriatric Medicine

15,298

$703K

480
450 are 65+

12%
patients receiving schedule two controlled substances

Avg: 14%

15%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $50

JOHN BAILEY D.O.

Geriatric Medicine

16,692

$722K

478
453 are 65+

12%
patients receiving schedule two controlled substances

Avg: 14%

18%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $50

WILLIAM GIBBONS MD

Geriatric Medicine

10,078

$572K

454
419 are 65+

8%
patients receiving schedule two controlled substances

Avg: 14%

4%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $50

ROGER ZIONCHECK M.D.

Geriatric Medicine

12,741

$581K

442
391 are 65+

14%
patients receiving schedule two controlled substances

Avg: 14%

19%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $50

CAROL SLOMPAK-PATTON MD

Geriatric Medicine

6,791

$339K

434
400 are 65+

4%
patients receiving schedule two controlled substances

Avg: 14%

4%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $50

KARL SCHWABE MD

Geriatric Medicine

9,498

$510K

423
360 are 65+

8%
patients receiving schedule two controlled substances

Avg: 14%

8%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $50

MICHELLE SCANNAPIECO MD

Geriatric Medicine

16,363

$939K

419
395 are 65+

13%
patients receiving schedule two controlled substances

Avg: 14%

12%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $50

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank